Related Experiment Video
Updated: Jan 11, 2026

Arterial Pouch Microsurgical Bifurcation Aneurysm Model in the Rabbit
Published on: May 14, 2020
Long-Term Outcomes of Coronary Artery Aneurysms in Children With Kawasaki Disease: A Systematic Review
Shoaib Syed Mohammed Shafy1, Karla Andrea Calderón Salavarria2, Sara Saleh3
1Critical Care Medicine, Yenepoya Medical College and Research Center, Mangalore, IND.
Insights
Kawasaki disease (KD) can cause coronary artery aneurysms (CAAs) in children. Early IVIG treatment improves CAA regression, while giant aneurysms require aggressive management and surveillance.
Area of Science:
- Pediatric Cardiology
- Rheumatology
- Vascular Biology
Background:
- Kawasaki disease (KD) is a leading cause of acquired pediatric heart disease.
- Coronary artery aneurysms (CAAs) are the most serious complication of KD, leading to long-term morbidity and mortality.
- Understanding long-term CAA outcomes is crucial for patient management.
Purpose of the Study:
- To systematically review the long-term outcomes of CAAs in children with KD.
- To analyze CAA regression rates, associated complications, and the impact of medical and surgical interventions.
- To provide evidence for optimizing the long-term care and surveillance of KD patients with CAAs.
Main Methods:
- Systematic review of 21 studies.
- Inclusion of 10,922 patients diagnosed with KD and CAAs.
- Analysis of data on CAA incidence, regression, complications, and treatment outcomes.
Main Results:
- CAA incidence in KD ranged from 3% to 27%, predominantly in infants under 6 months.
- Most small and moderate CAAs (>80%) regressed, unlike giant aneurysms.
- Early intravenous immunoglobulin (IVIG) treatment improved regression rates; left anterior descending artery aneurysms showed less regression.
- Complications included thrombosis, myocardial infarction, major adverse cardiac events, and cardiac death.
- Coronary artery bypass grafting was the primary surgical intervention.
Conclusions:
- Early and aggressive management of KD with IVIG, potentially escalated with steroids or biologics, is preferred.
- Surgical intervention is indicated for giant or persistent CAAs.
- Timely diagnosis, risk stratification, and standardized guidelines are essential for optimal long-term care and surveillance of KD patients with CAAs.
Abstract:
Kawasaki disease (KD) is a systemic inflammation of the blood vessels seen in children. It is the leading cause of acquired heart disease. Coronary artery aneurysm (CAA) is the most concerning complication, associated with long-term morbidity and mortality. This systematic review examined long-term outcomes of CAAs in KD, with emphasis on regression, complications, and the role of medical and surgical interventions. A total of 21 studies involving 10,922 patients were reviewed. The incidence of CAAs ranged from 3%-27%, mostly affecting infants under 6 months. Small and moderate aneurysms regressed in the majority of cases (>80%), whereas giant aneurysms were less likely to regress. Complications included thrombosis, myocardial infarction, major adverse cardiac events, and cardiac death. Early treatment with intravenous immunoglobulin (IVIG) enhanced the likelihood of regression. Aneurysms in the left anterior descending artery were less likely to regress, suggesting an anatomical influence. Coronary artery bypass grafting was the most common surgical intervention. Early and aggressive management with IVIG, with escalation to steroids or biologics when required, remains the preferred approach. Surgical intervention is sought for giant or persistent aneurysms. These findings emphasize the importance of timely diagnosis, risk stratification, and the establishment of standardized guidelines to optimize long-term care and surveillance of patients with KD.
More Related Videos
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
07:21Microsurgical Creation of Giant Bifurcation Aneurysms in Rabbits for the Evaluation of Endovascular Devices
Published on: September 8, 2023
Related Concept Videos
Aneurysm III: Interprofessional Care
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm I: Introduction
Coronary Artery Disease V: Interprofessional Care
Aortic Regurgitation III: Medical Management